Insider selling is trivial relative to market cap and does not warrant a bearish read. The Co-CEO's $1.52M sale is likely liquidity-driven given the small proportion of his stake. Monitor for any larger cluster or C-suite selling above 0.1% of market cap before adjusting view.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 25 $164.92entry
- T+1 · 3mo ago +3.64%α +3.62% · $170.92
- T+5 · 3mo ago −0.31%α +0.23% · $164.41
- T+20 · 8w ago +6.91%α +6.66% · $176.31
- T+58 · todayOpen
- T+60 · tomorrow Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Guardant Health (GH) insiders sold $1.54M in shares over the past week, led by Co-CEO AmirAli Talasaz who sold $1.52M in a single open-market transaction on August 21. Director Roberto Mignone exercised non-cash derivative positions with no economic value. The selling represents approximately 0.007% of GH's $22.9B market cap, a trivial amount that does not signal material bearish conviction.
Key Financial Metrics
Key Facts
- Co-CEO AmirAli Talasaz sold 9,023 shares at $168.20 for $1.52M on 2026-08-21
- Director Tariq Musa sold 116 shares at $156.45 for $18K on 2026-08-17
- Director Roberto Mignone exercised non-cash derivative options (264 shares at $0) on 2026-08-21
- Total cluster value of $1.54M is only 0.007% of GH's $22.9B market cap
- No open-market buying activity in the cluster
Financial Impact
$1.54M in total insider sales, representing 0.007% of market cap
Risk Factors
- Co-CEO selling could be perceived negatively by retail investors despite trivial size
- No insider buying to signal confidence at current $168 price level
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GH-1787645320556 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers